HOME > Investor Relations > Financial Highlights

Financial Highlights

At a Glance

  • Sales by Reportable Segments

    Sales by Reportable Segments

  • Operating Profit and Operating Profit Ratio on Sales

    Operating Profit and Operating Profit Ratio on Sales<

  • Net Income and Return on Equity

    Net Income and Return on Equity

(Unit: millions of yen)

FY
2015
FY
2016
FY
2017
FY
2018
FY
2014
Sales by Reportable Segments 48,260 49,843 47,866 52,241 59,389
Electonics Materials 48,258 48,302 46,450 49,854 48,086
Medical and Pharmaceuticals 819 7,661
Other 2 1,540 1,415 1,567 3,642
Operating Profit 9,254 10,964 9,221 11,337 8,099
Net Income 6,667 7,796 6,398 4,856 4,443
Operating Profit Ratio on Sales (%) 19.2 22.0 19.3 21.7 13.6
Return on Equity (%) 16.7 19.0 11.2 6.8 6.3

Financial Indicators

  • Total Assets and Return on Assets

    Total Assets and Return on Assets

  • Shareholders' Equity and Shareholders' Equity Ratio

    Shareholders' Equity and Shareholders' Equity Ratio

  • Capital Expenditure

    Capital Expenditure

  • Depreciation and
    Amortization Expenditure

    Depreciation and Amortization Expenditure

  • R&D Expenditure

    R&D Expenditure

  • Number of Employees

    Number of Employees

(Unit: millions of yen)

FY
2015
FY
2016
FY
2017
FY
2018
FY
2014
Total Assets 61,241 65,464 92,386 111,490 105,666
Shareholders' Equity 39,073 43,115 71,063 72,659 70,183
Capital Expenditure 3,321 4,055 1,722 (※1) 1,565 6,924
Depreciation and
Amortization Expenditure
1,411 1,891 2,485 (※2) 1,941 (※2) 2,557
R&D Expenditure 2,213 2,441 3,235 3,089 3,116
Return on Assets (%) 10.9 11.9 6.9 4.4 4.2
Shareholders' Equity Ratio (%) 63.8 65.9 76.9 65.2 66.4
Number of Employees 1,122 1,202 1,249 1,268 1,614

※1 Capital expenditure does not include sales rights of 13 long-term listed products.
※2 Depreciation does not include amortization of sales rights mentioned above.